Publications by authors named "Uday Popat"

100Publications

Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2020 Sep 16. Epub 2020 Sep 16.

Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.09.003DOI Listing
September 2020

Improving Survival After Transplant in Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2020 Sep;20 Suppl 1:S72-S73

University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2152-2650(20)30468-7DOI Listing
September 2020

A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2020 Sep;20 Suppl 1:S19

University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2152-2650(20)30447-XDOI Listing
September 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Haploidentical transplants for patients with relapse after the first allograft.

Am J Hematol 2020 Jul 3. Epub 2020 Jul 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25924DOI Listing
July 2020

Haploidentical transplants for patients with graft failure after the first allograft.

Am J Hematol 2020 Jun 29. Epub 2020 Jun 29.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25917DOI Listing
June 2020

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2020 01 10;26(1):197-203. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.006DOI Listing
January 2020

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.

Am J Hematol 2019 06 3;94(6):E176-E180. Epub 2019 Apr 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25470DOI Listing
June 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 05 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183059
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.032DOI Listing
March 2019

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.

Exp Hematol 2018 11 10;67:49-59.e1. Epub 2018 Aug 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2018.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262883PMC
November 2018

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation.

Hematol Oncol Stem Cell Ther 2019 Jun 31;12(2):115-118. Epub 2018 Jan 31.

Section of Benign Hematology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2017.09.001DOI Listing
June 2019

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.

Br J Haematol 2018 12 19;183(5):831-835. Epub 2017 Dec 19.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15059DOI Listing
December 2018

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Eur J Haematol 2017 Dec 8;99(6):532-535. Epub 2017 Oct 8.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12970DOI Listing
December 2017

Risk factors for falls in older patients with cancer.

BMJ Support Palliat Care 2018 Mar 31;8(1):34-37. Epub 2017 Aug 31.

Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2017-001388DOI Listing
March 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

Biol Blood Marrow Transplant 2017 Aug 12;23(8):1359-1366. Epub 2017 May 12.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453532PMC
August 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141702PMC
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Neurology 2017 Feb 1;88(9):842-852. Epub 2017 Feb 1.

From the Colorado Blood Cancer Institute (R.A.N.), Denver; Baylor College of Medicine (G.J.H.), Houston, TX; Ohio State University (M.K.R., S.M.D.), Columbus; MD Anderson Cancer Research Center (U.P.), Houston, TX; Rho, Inc. (K.C.S.), Chapel Hill, NC; National Institute of Allergy and Infectious Diseases (L.M.G.), National Institutes of Health, Bethesda, MD; Division of Brain Sciences (P.A.M.), Imperial College London, UK; City of Hope National Medical Center (H.O.), Duarte, CA; Immune Tolerance Network (P.H.S.), University of California San Francisco; University of Texas Southwestern (O.S.), Dallas; NeuroRx (D.L.A.), McGill University, Montreal, Canada; Fred Hutchinson Cancer Research Center (G.E.G.), University of Washington (M.H.W., A.W., G.H.K.); and Swedish Hospital Medical Center (J.D.B.), Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868PMC
February 2017

Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation.

Pulm Circ 2016 Dec;6(4):611-613

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/687291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210054PMC
December 2016

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Bonekey Rep 2016 19;5:843. Epub 2016 Oct 19.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bonekey.2016.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154364PMC
October 2016

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

Eur J Haematol 2017 Mar 1;98(3):263-268. Epub 2016 Dec 1.

Department of Stem Cell Transplantation and Cellular therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12826DOI Listing
March 2017

Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies.

AIDS 2016 11;30(17):2653-2657

aDepartment of Infectious Diseases, Infection Control and Employee Health bDepartment of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625294PMC
November 2016